Abstract
Management of tachyarrhythmias includes at least one of the following goals: 1) termination of the arrhythmia, 2) control of the ventricular response, or 3) prevention of recurrences. Many cardioactive drugs have antiarrhythmic activity even if they are not primarily determined to be antiarrhythmic agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Szekeres L, Vaughan Williams EM: Antifibrillatory action. J Physiol 160:470, 1962.
Vaughan Williams EM: Subgroups of class 1 antiarrhythmic drugs. Eur Heart J 5:96, 1984.
Touboul P, et al: Effects electrophysiologiques des agents antiarythmiques chez l’homme: tentative de classification. Arch Mal Coeur 72:72, 1979.
Vaughan Williams EM: The classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen F, Oleson KH (eds) Symposium on cardiac arrhythmias. AB Astra, Sodertalje, Sweden, 1970, p 449.
Bassett AL, Hoffman BF: Anti-arrhythmic drugs: electrophysiological actions. Annu Rev Pharmacol 11:143, 1971.
Singh BN, Hauswirth O: Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J 87:367, 1974.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Schneeweiss, A., Schettler, G. (1988). Introduction. In: Cardiovascular Drug Therapy in the Elderly. Developments in Cardiovascular Medicine, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2063-0_23
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2063-0_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9225-8
Online ISBN: 978-1-4613-2063-0
eBook Packages: Springer Book Archive